UB Paderborn / Katalog / Suche / in CDI

Antibiotic Resistance — Problems, Progress, and Prospects

The New England journal of medicine, 2014-11, Vol.371 (19), p.1761-1763

2014

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial resistance-a threat to the world's sustainable development

Upsala journal of medical sciences, 2016-08, Vol.121 (3), p.159-164

2016

Link zum Volltext

Verfügbarkeit prüfen

Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamases: a Prospective Study with Swedish Volunteers

Antimicrobial Agents and Chemotherapy, 2010-09, Vol.54 (9), p.3564-3568

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization

Antimicrobial Agents and Chemotherapy, 2011-10, Vol.55 (10), p.4619-4630

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli

Antimicrobial agents and chemotherapy, 2008-03, Vol.52 (3), p.813-821

2008

Link zum Volltext

Verfügbarkeit prüfen

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

The Lancet infectious diseases, 2015-02, Vol.15 (2), p.225-234

2015

Link zum Volltext

Verfügbarkeit prüfen

Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4241-4249

2012

Link zum Volltext

Verfügbarkeit prüfen

Protein Binding: Do We Ever Learn?

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3067-3074

2011

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Drug Exposure to Minimize Selection of Antibiotic Resistance

Clinical infectious diseases, 2007-09, Vol.45 (Supplement-2), p.S129-S136

2007

Link zum Volltext

Verfügbarkeit prüfen

Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is now

Drug resistance updates, 2011-04, Vol.14 (2), p.118-124

2011

Link zum Volltext

Verfügbarkeit prüfen

An international legal framework to address antimicrobial resistance

Bulletin of the World Health Organization, 2015-02, Vol.93 (2), p.66-66

2015

Link zum Volltext

Verfügbarkeit prüfen

Resetting the agenda for antibiotic resistance through a health systems perspective

The Lancet global health, 2021-07, Vol.9 (7), p.e1022-e1027

2021

Link zum Volltext

Verfügbarkeit prüfen

Variation in antibiotic use in the European Union

The Lancet (British edition), 2001-06, Vol.357 (9271), p.1851-1853

2001

Link zum Volltext

Verfügbarkeit prüfen

Quantifying combined effects of colistin and ciprofloxacin against Escherichia coli in an in silico pharmacokinetic-pharmacodynamic model

Scientific reports, 2024-05, Vol.14 (1), p.11706-11706, Article 11706

2024

Link zum Volltext

Verfügbarkeit prüfen

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

Journal of antimicrobial chemotherapy, 2005-05, Vol.55 (5), p.601-607

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic-Pharmacodynamic Model for Gentamicin and Its Adaptive Resistance with Predictions of Dosing Schedules in Newborn Infants

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.179-188

2012

Link zum Volltext

Verfügbarkeit prüfen

Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration

Antimicrobial Agents and Chemotherapy, 2013-01, Vol.57 (1), p.668-671

2013

Link zum Volltext

Verfügbarkeit prüfen

Serum and Cerebrospinal Fluid Levels of Colistin in Pediatric Patients

Antimicrobial Agents and Chemotherapy, 2010-09, Vol.54 (9), p.3985-3987

2010

Link zum Volltext

Verfügbarkeit prüfen

Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS

Journal of pharmaceutical and biomedical analysis, 2009-04, Vol.49 (3), p.760-767

2009

Link zum Volltext

Verfügbarkeit prüfen

The language of antimicrobial and antibiotic resistance is blocking global collective action

Infectious diseases (London, England), 2024-06, Vol.56 (6), p.487-495

2024

Link zum Volltext

Verfügbarkeit prüfen

Predicting In Vitro Antibacterial Efficacy across Experimental Designs with a Semimechanistic Pharmacokinetic-Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1571-1579

2011

Link zum Volltext

Verfügbarkeit prüfen

Semimechanistic Pharmacokinetic/Pharmacodynamic Model for Assessment of Activity of Antibacterial Agents from Time-Kill Curve Experiments

Antimicrobial Agents and Chemotherapy, 2007-01, Vol.51 (1), p.128-136

2007

Link zum Volltext

Verfügbarkeit prüfen

Otto Cars: reacting to antimicrobial resistance

Bulletin of the World Health Organization, 2019-06, Vol.97 (6), p.384-385

Humphreys, Gary

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic Effects of Telavancin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains in the Presence of Human Albumin or Serum and in an In Vitro Kinetic Model

Antimicrobial Agents and Chemotherapy, 2007-09, Vol.51 (9), p.3311-3316

2007

Link zum Volltext

Verfügbarkeit prüfen

Posaconazole in Human Serum: a Greater Pharmacodynamic Effect than Predicted by the Non-Protein-Bound Serum Concentration

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3099-3104

2011

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Antibiotic Resistance — Problems, Progress, and Prospects

Antimicrobial resistance-a threat to the world's sustainable development

Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamases: a Prospective Study with Swedish Volunteers

Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization

Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

Protein Binding: Do We Ever Learn?

Optimizing Drug Exposure to Minimize Selection of Antibiotic Resistance

Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is now

An international legal framework to address antimicrobial resistance

Resetting the agenda for antibiotic resistance through a health systems perspective

Variation in antibiotic use in the European Union

Quantifying combined effects of colistin and ciprofloxacin against Escherichia coli in an in silico pharmacokinetic-pharmacodynamic model

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

Pharmacokinetic-Pharmacodynamic Model for Gentamicin and Its Adaptive Resistance with Predictions of Dosing Schedules in Newborn Infants

Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration

Serum and Cerebrospinal Fluid Levels of Colistin in Pediatric Patients

Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS

The language of antimicrobial and antibiotic resistance is blocking global collective action

Predicting In Vitro Antibacterial Efficacy across Experimental Designs with a Semimechanistic Pharmacokinetic-Pharmacodynamic Model

Semimechanistic Pharmacokinetic/Pharmacodynamic Model for Assessment of Activity of Antibacterial Agents from Time-Kill Curve Experiments

Otto Cars: reacting to antimicrobial resistance

Pharmacodynamic Effects of Telavancin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains in the Presence of Human Albumin or Serum and in an In Vitro Kinetic Model

Posaconazole in Human Serum: a Greater Pharmacodynamic Effect than Predicted by the Non-Protein-Bound Serum Concentration

Suchergebnisse filtern